Literature DB >> 16511968

Hemoglobin and heme scavenging.

Paolo Ascenzi1, Alessio Bocedi, Paolo Visca, Fiorella Altruda, Emanuela Tolosano, Tiziana Beringhelli, Mauro Fasano.   

Abstract

Release of hemoglobin into plasma is a physiological phenomenon associated with intravascular hemolysis. In plasma, stable haptoglobin-hemoglobin complexes are formed and these are subsequently delivered to the reticulo-endothelial system by CD163 receptor-mediated endocytosis. Heme arising from the degradation of hemoglobin, myoglobin, and of enzymes with heme prosthetic groups could be delivered in plasma. Albumin, haptoglobin, hemopexin, and high and low density lipoproteins cooperate to trap the plasma heme, thereby ensuring its complete clearance. Then hemopexin releases the heme into hepatic parenchymal cells only after internalization of the hemopexin-heme complex by CD91 receptor-mediated endocytosis. Moreover, alpha1-microglobulin contributes to heme degradation by a still unknown mechanism, with the concomitant formation of heterogeneous yellow-brown kynurenine-derived chromophores which are very tightly bound to amino acid residues close to the rim of the lipocalin pocket. During hemoglobin synthesis, the erythroid alpha-chain hemoglobin-stabilizing protein specifically binds free alpha-hemoglobin subunits limiting the free protein toxicity. Although highly toxic because capable of catalyzing free radical formation, heme is also a major and readily available source of iron for pathogenic organisms. Gram-negative bacteria pick up the heme-bound iron through the secretion of a hemophore that takes up either free heme or heme bound to heme-proteins and transports it to a specific receptor, which, in turn, releases the heme and hence iron into the bacterium. Here, hemoglobin and heme trapping mechanisms are summarized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511968     DOI: 10.1080/15216540500380871

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  82 in total

1.  Comparison of AngioJet rheolytic pharmacomechanical thrombectomy versus AngioJet rheolytic thrombectomy in a porcine peripheral arterial model.

Authors:  Peter H Lin; Firas F Mussa; Nasim Hedayati; Joseph J Naoum; Wei Zhou; Qizhi Yao; Panagiotis Kougias; Hosam F El Sayed; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

2.  Functionally distinct NEAT (NEAr Transporter) domains within the Staphylococcus aureus IsdH/HarA protein extract heme from methemoglobin.

Authors:  Rosemarie M Pilpa; Scott A Robson; Valerie A Villareal; Melissa L Wong; Martin Phillips; Robert T Clubb
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

3.  Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin.

Authors:  Ivan Azarov; Xiaojun He; Anne Jeffers; Swati Basu; Burak Ucer; Roy R Hantgan; Andrew Levy; Daniel B Kim-Shapiro
Journal:  Nitric Oxide       Date:  2008-03-08       Impact factor: 4.427

Review 4.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

5.  Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.

Authors:  Xiurong Zhao; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

Review 6.  The Iron age of host-microbe interactions.

Authors:  Miguel P Soares; Günter Weiss
Journal:  EMBO Rep       Date:  2015-10-16       Impact factor: 8.807

7.  Fluoride and azide binding to ferric human hemoglobin:haptoglobin complexes highlights the ligand-dependent inequivalence of the α and β hemoglobin chains.

Authors:  Paolo Ascenzi; Alessandra di Masi; Giovanna De Simone; Magda Gioia; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2019-01-31       Impact factor: 3.358

8.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

9.  Heme-hemopexin complex attenuates neuronal cell death and stroke damage.

Authors:  Rung-chi Li; Sofiyan Saleem; Gehua Zhen; Wangsen Cao; Hean Zhuang; Jongseok Lee; Ann Smith; Fiorella Altruda; Emanuela Tolosano; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-11       Impact factor: 6.200

10.  HFE-Related Hemochromatosis: The Haptoglobin 2-2 Type Has a Significant but Limited Influence on Phenotypic Expression of the Predominant p.C282Y Homozygous Genotype.

Authors:  Gérald Le Gac; Chandran Ka; Isabelle Gourlaouen; Laurence Bryckaert; Anne-Yvonne Mercier; Brigitte Chanu; Virginie Scotet; Claude Férec
Journal:  Adv Hematol       Date:  2009-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.